The first US patient has been enrolled at Medstar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to … continue reading “SELUTION SLR Coronary Sirolimus DEB Study: First US Patient Enrolled”
Specialty
Breast Cancer EU Study Patients for CairnSurgical BCLTM System
CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, has announced that the first patients have been … continue reading “Breast Cancer EU Study Patients for CairnSurgical BCLTM System”
New Commercial Operations VP for LimFlow
LimFlow SA has announced the appointment of Mike Mathias as Vice President of Commercial Operations. The company is a pioneer in … continue reading “New Commercial Operations VP for LimFlow”
Venous Leg Ulcers; Economics and MedTech’s Answers
Technological advancements such as Sky Medical Technology‘s wearable geko™ device mark a new era in the treatment of Venous Leg … continue reading “Venous Leg Ulcers; Economics and MedTech’s Answers”
Neuromodulation specialist CVRx Launches new Barostim NEO2™ Implantable Pulse Generator
CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has launched its … continue reading “Neuromodulation specialist CVRx Launches new Barostim NEO2™ Implantable Pulse Generator”
Wigs for Heroes Fund Scalp Cooling Equipment
Here’s a nice tale of how a medical technology can improve a treatment journey. Cancer patients receiving chemotherapy at North … continue reading “Wigs for Heroes Fund Scalp Cooling Equipment”
First-in-Human Trial will Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation
Swiss company Argá Medtech has begun enrollment in a First-in-Human Clinical Trial of its CSE Ablation System in the treatment … continue reading “First-in-Human Trial will Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation”
FDA Clears First Spine Device for Ligament Augmentation
Medtronic plc, has received U.S. FDA 510(k) clearance and Breakthrough Device designation for its novel LigaPASS™ 2.0 Ligament Augmentation System. … continue reading “FDA Clears First Spine Device for Ligament Augmentation”
Social Media Key to Chronic Disease Management in Gen Zers, Says Software Tool Developer
LovedBy, the health technology and consultancy business, has announced the launch of ‘Nudg with Dexcom’ directly to Gen Z in … continue reading “Social Media Key to Chronic Disease Management in Gen Zers, Says Software Tool Developer”
First Limus Drug-eluting Balloon for US as SELUTION SLR™ Gets FDA IDE Approval
MedAlliance’s SELUTION SLR™ drug-eluting balloon (DEB) has received FDA Investigational Device Exemption (IDE) approval, making it the first limus DEB … continue reading “First Limus Drug-eluting Balloon for US as SELUTION SLR™ Gets FDA IDE Approval”
CVRx®Barostim™ Heart Failure System Gains MR-Conditional Labeling Approval
CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has received U.S. … continue reading “CVRx®Barostim™ Heart Failure System Gains MR-Conditional Labeling Approval”
Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™
Biosensors International Group, Ltd. has announced the Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™. Background … continue reading “Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™”
Myopia in Childhood: Screens to Blame
Cases of Myopia (near-sightedness) have doubled since the 1960s and will double again by 2050 according to the WHO. Now … continue reading “Myopia in Childhood: Screens to Blame”
First O.U.S. Patients Get TRIA Biopolymer Surgical Aortic Valve™
Foldax®, Inc. says the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of … continue reading “First O.U.S. Patients Get TRIA Biopolymer Surgical Aortic Valve™”
Study Shows Promise for Next-Generation Cardiac Ablation Tech
Argá Medtech’s next-generation non-thermal cardiac ablation system shows promise in improving precision, speed and flexibility in treating atrial fibrillation, says … continue reading “Study Shows Promise for Next-Generation Cardiac Ablation Tech”
$40M New Funding to Prevent Amputations
LimFlow SA, has closed a $40 million (€36 million) oversubscribed Series D financing round. The company is a pioneer in the … continue reading “$40M New Funding to Prevent Amputations”